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ABSTRACT The developmental origin of dendritic cells, a
specialized system ofmajor histocompatibility complex (MHC)
class 11-rich antigen-presenting cells for T-celi immunity and
tolerance, is not well characterized. Granulocyte-macrophage
colony-stimulating factor (GM-CSF) is known to stimulate
dendritic cells, including growth and development from MHC
class 11-negative precursors in suspension cultures of mouse
bone marrow. Here we studied colony formation in semi-solid
methylcellulose cultures, a classical bioassay system in which
GM-CSF induces the formation of mixed granulocyte-
macrophage colonies. When colonies were induced from MHC
class II-negative precursors, a small subset (1-2%) of typical
dendritic cells developed alongside macrophages and granulo-
cytes. The dendritic cells were distinguished by their cytologic
features, high levels of MHC class II products, and distinct
intracellular granule antigens. By using differential adherence
to plastic, enriched populations ofthe various myeloid cell types
were isolated from colonies. Only the dendritic cells stimulated
a primary T-celi immune response, the mixed leukocyte reac-
tion, and the potency was comparable to typical dendritic cells
isolated from spleen. Macrophages from mixed or pure colonies
were inactive as stimulator cells. Therefore, three distinct
pathways of myeloid development-granulocytes, macro-
phages, and dendritic cells-can develop from a commonMHC
class fl-negative progenitor under the aegis of GM-CSF.
Dendritic cells constitute a system of antigen-presenting cells
in the T-cell-dependent areas of lymphoid tissues and at the
portals of antigen entry into the body such as skin, airway
epithelium, and afferent lymph. These cells express high
levels of antigen-presenting major histocompatibiity com-
plex (MHC) class II products, cell surface adhesion and
costimulatory molecules (1), and certain cytoplasmic anti-
gens localized primarily within intracellular granules (2, 3).
Dendritic cells act as specialized accessories to induce im-
munity (4) and tolerance (5-7). In contrast to other hemato-
poietic cells, the developmental lineage of dendritic cells is
not worked out.
A relationship of dendritic cells to phagocytes is suggested
by the shared responsiveness of these cells to granulocyte-
macrophage colony-stimulating factor (GM-CSF). GM-CSF
maintains dendritic-cell viability (8-11) and mediates their
development from less-mature but nonproliferating precur-
sors in skin (8, 9). More recently, GM-CSF has been shown
to induce the extensive growth of dendritic-cell precursors in
suspension cultures (12-14). In these cultures, the mature
nonproliferating progeny express high levels ofMHC class II
and other marker antigens that are characteristic of dendritic
cells. Interestingly, dendritic cells do not respond to the more
lineage-restricted macrophage and granulocyte colony-
stimulating factors (M-CSF and G-CSF, respectively) (8, 10,
12).
Since GM-CSF can induce the formation of mixed popu-
lations ofgranulocytes and macrophages in semi-solid colony
systems (15), we asked whether dendritic cells could also
arise from a colony-forming precursor that is common to
phagocytes. Cells with some of the features of dendritic cells
have been detected in human cell colonies that were induced
with lectin-conditioned medium (16) and more recently with
a mixture of tumor necrosis factor and GM-CSF (17). Here
we isolate cells from colonies that are induced by recombi-
nant GM-CSF from MHC class II-negative precursors and
show that the colonies contain significant numbers of den-
dritic cells by several criteria. The dendritic cells are readily
distinguished from phagocytes particularly in their high levels
ofMHC class II expression, content ofintracellular antigens,
and antigen-presenting-cell function. Dendritic cells, there-
fore, represent a distinct immunostimulatory differentiation
pathway that is induced by GM-CSF but shares a common
MHC class II-negative precursor with phagocytes.
MATERIALS AND METHODS
Marrow Cells and Cultures. Bone marrow suspensions were
prepared from 6- to 8-week-old (BALB/c x DBA/2)F1 mice
as described, including treatment with monoclonal antibodies
and complement to deplete cells bearing MHC class II, CD4,
CD8, and B220 markers (13). Approximately 6 x 104 cells from
BALB/c x DBA/2 adult male mice were suspended in 1 ml of
culture medium [RPMI 1640 medium/10% (vol/vol) fetal calf
serum/50 uM 2-mercaptoethanol, gentamicin (20 ,ug/ml)] in
the presence of 1% methylcellulose (Nakarai Tesque, Kyoto)
and recombinant mouse GM-CSF (2000-4000 units/ml, 9.2 x
107 units/mg; Kirin Brewery, Takasaki, Gunma) and applied
to 35-mm Petri dishes (Falcon, 3001).
Phenotype ofMarrow Cells. After 5 or 6 days ofculture, ""50
mixed colonies were plucked with a Pasteur pipette from the
methylcellulose, resuspended, washed, and cytocentrifuged
onto glass slides (Shandon, Sewickley, PA). The cytocentri-
fuged cells were stained with Giemsa (Wako Pure Chemical,
Osaka) or were fixed with absolute acetone and stained with
monoclonal antibodies (see Results) followed by peroxidase-
conjugated anti-immunoglobulin as described (13). To observe
the distinctive morphology of dendritic cells in live prepara-
tions, the colonies were examined at a final magnification of
x40 to x 100. To separate the various cell types that are found
in colonies, 200-300 colonies were pooled and separated into
three fractions on the basis ofdifferential adherence to plastic.
Abbreviations: MHC, major histocompatibility complex; GM-CSF,
granulocyte-macrophage colony-stimulating factor; MLR, mixed
leukocyte reaction.
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The cells were applied in culture medium to 35-mm tissue
culture dishes and after 2 hr were separated into nonadherent
(granulocytes and some dendritic cells), weakly adherent
(dislodged by gentle pipetting), and strongly adherent [dis-
lodged after 20 min of culture at 37°C in phosphate-buffered
saline (PBS) with 10 mM EDTA].
Stimulation of the Mixed Leukocyte Reaction (MLR). En-
riched populations of dendritic cells and macrophages were
prepared from pools of bone marrow colonies as above,
treated with mitomycin C (Kyowa Hakko, Tokyo), and
applied in graded doses to 3 x 105 purified T cells from
allogeneic C3H/He mice. DNA synthesis in the responding
T cells was measured with a pulse of 1 ACi of [3H]thymidine
(1 Ci = 37 GBq) administered at 72-90 h of culture. Data with
syngeneic T cells as responders were <10% of the corre-
sponding response with allogeneic T cells.
RESULTS
A slightly modified colony-forming assay was used to eval-
uate the effect of GM-CSF on mouse bone marrow progen-
itors. Since a hallmark of the mature dendritic cell is the
abundant expression of MHC class II products, we first
treated the marrow suspensions with antibodies and comple-
ment to deplete cells that express MHC class II and the
lymphocyte antigens B220, CD4, and CD8. Treatment with
antibody and complement removed detectable B and T
lymphocytes from suspension cultures (12, 13). Small num-
bers of the treated marrow cells (or unmanipulated bone












Table 1. Yields of colony-forming units from bone marrow
depleted of T, B, and MHC class II-rich cells
Colony-forming units, no. per
Type of colony 105 bone marrow cells
Granulocyte 79 ± 12
Mixed-type 108 ± 15
Macrophage 57 ± 14
Eosinophil 10 ± 2
Burst 1.6 ± 0.9
Values are the means ± SEM of quadruplicate assays in four
experiments.
were then suspended in medium that was made semi-solid by
adding methylcellulose and was supplemented with fetal calf
serum and various cytokines. We found it helpful to omit the
horse serum, a standard supplement in this culture system. At
5-8 days, colonies appeared, many of which were of the
"mixed" type containing more compact round cells and
many dispersed cells. The yield of different types of colonies
is shown in Table 1. By several criteria, we were able to show
that some of the dispersed cells were typical dendritic cells as
long as GM-CSF (but not interleukin 3, M-CSF, or G-CSF)
had been used to generate the colonies.
Identification of Cells with the Phenotype of Dendritic Cells.
Under phase-contrast microscopy, the presumptive dendritic
cells in individual colonies extended distinct processes in
many directions from the cell body. These large lamellipodia
or "veils" are characteristic of dendritic cells from many






























FIG. 1. Identification of dendritic cells in mixed colonies of macrophages and granulocytes at day 5 and 6 of culture in GM-CSF. Presumptive
dendritic cells in these cytocentrifuged preparations of pooled colonies are indicated by arrows, except in d and i where granulocytes are
identified. (a-f and h-j, x 100; g, x250.) (a and f) Giemsa stain. Macrophages are round and heavily vacuolated; dendritic cells (arrows) are
larger, less-vacuolated, and have many spinous processes. (b and g) MHC class II antigens (monoclonal B21-2, ATCC TIB229) are strongly
expressed on a subset of larger spiny cells. (c and h) 2A1 intracellular antigen, found in the perinuclear region of dendritic cells but not phagocytes
(unpublished data), stains a subset of the colony cells. (d and i) RB6-8C2 granulocyte antigen. (e and j) FA1l intracellular granule antigen of
macrophages (21). A few mononuclear cells, presumably the dendritic cells, are FAll-negative.
a
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FIG. 2. Higher-power views of intracellular antigens within the endocytic vacuolar system. Cytocentrifuged cells from 6-day colonies were
stained by 2A1 anti-dendritic cell (a), FAll anti-macrophage (b), and MAC-3 anti-lysosome (c) antibodies. The less-vacuolated dendritic cells
(arrows) stain strongly for 2A1 but more weakly for FAll and MAC-3 antigens. The reciprocal applies to heavily vacuolated macrophages.
for examination with the standard Giemsa hematologic stain
(Fig. 1 a and f). Three cell types were evident. There were
typical macrophages (i.e., large round mononuclear cells
with many cytoplasmic vacuoles). There also were granulo-
cytes (cells with a pale cytoplasm but characteristic irregu-
larly shaped condensed nuclei often assuming a "doughnut"
shape). Then, there were mononuclear profiles (Fig. 1 a and
f, arrows; usually larger than most of the phagocytes, with an
irregular "frilly" shape and few cytoplasmic vacuoles).
After staining with antibodies to MHC class II antigens, the
large cells were stained very strongly and selectively, and the
dendritic processes were clearly evident (Fig. 1 b and g,
arrows). When we applied the M342 (3) or 2A1 (unpublished
data) monoclonal antibodies that recognize cytoplasmic vac-
uoles within dendritic cells and some B cells (but not phago-
cytes), a subset of cells again stained selectively (Fig. 1 c and
h, arrows; Fig. 2a). Granulocytes were further identified with
the RB6 monoclonal antibody (Fig. 1 d and i, arrows). The
FAll monoclonal antibody (22), which identifies a "macro-
sialin" that is abundant in cytoplasmic granules of macro-
phages (21), stained most of the mononuclear cells in the
colonies. However, some FAll-weak presumptive dendritic
cells were also noted (Fig. 1 e and j, arrows; Fig. 2b). A
monoclonal antibody (MAC-3) to a lysosomal membrane
glycoprotein stained the phagocytes strongly relative to the
weak stain on presumptive dendritic cells (Fig. 2c).
The yield of the subset of MHC class II-rich and 2A1
cytoplasmic antigen-positive cells was determined in colo-
nies at different times. At the peak, day 5-6, the presumptive
dendritic cells represented 0.5-1.5% of the progeny (Table 2).
Table 2. Frequency of dendritic cells arising in mixed colonies
generated from MHC class II-negative bone marrow precursors
Day of MHC class II- 2A1-positive
colony assay rich cells, % cells, %
4 0.11 0.09 ND
5 0.55 ± 0.23 0.07 ± 0.04
6 1.47 + 0.34 0.48 ± 0.23
7 1.39 ± 0.28 0.50 ± 0.21
8 0.73 + 0.12 0.21 ± 0.08
Values are the means ± SEM of three experiments in which >400
cells were counted in cytocentrifuged cells harvested from mixed
colonies.
Prior work has shown that the 2A1 and M342 cytoplasmic
antigens appear relatively late in dendritic-cell development,
after the cell has stopped proliferating, whereas MHC class
II is expressed during and after growth (12, 13). We conclude
that GM-CSF induces MHC class IT-negative precursors to
form mixed colonies that contain typical phagocytes (mac-
rophages and granulocytes) plus some dendritic cells, as
assessed by cytologic features and surface and intracellular
antigens.
Separation of Colony-Derived Macrophages and Dendritic
Cells. To verify that all the distinctive markers of dendritic
cells (Figs. 1 and 2) were being expressed by the same
population, we pooled the cells from many colonies and
prepared macrophage- and dendritic-cell-enriched popula-
tions by using adherence criteria. It is known that dendritic
cells, unlike macrophages, do not stick firmly to plastic
surfaces (19, 20, 23).
When colony-derived cells were applied to plastic, the bulk
of the granulocytes and some of the dendritic cells were
nonadherent and could be removed by swirling the plates.
When we gently pipetted buffer over the remaining adherent
cells, most of the dendritic cells were dislodged as verified by
double labeling for MHC class II and the 2A1 intracellular
dendritic cell antigen (Fig. 3 a-c; e.g., cells at arrows), but not
the FAll macrophage granule antigen (data not shown). The
vacuolated phagocytes remained firmly attached and could
only be dislodged after warming the cultures in PBS supple-
mented with 10 mM EDTA. Almost all the cells in the firmly
attached population (Fig. 3d) had low or absent MHC class
TI (Fig. 3e), and expressed the FAll antigen that is abundant
in macrophage granules (Fig. 3f), but lacked 2A1 (data not
shown). In addition, macrophages expressed much higher
levels of the lysosomal membrane glycoprotein detected by
the MAC-3 monoclonal antibody than did dendritic cells (data
not shown). With additional GM-CSF, we could not convert
the phagocytes to dendritic cells or vice versa.
Function of Colony-Derived Dendritic Cells and Macro-
phages. The enriched populations (nonadherent, weakly ad-
herent, and firmly adherent) were then evaluated for immu-
nostimulatory activity by using the MLR as a test system. In
the MLR, leukocytes from one strain of mice, particularly
dendritic cells (25, 26), initiate a strong proliferative response
in T cells from other strains that differ in MHC. Stimulation
of the MLR requires presentation of the foreign MHC prod-
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FIG. 3. Two-color immunofluorescence to test for coexpression ofMHC class II and other antigens in enriched bone-marrow-colony-derived
dendritic cells and macrophages. Cells were double-labeled for MHC class II and either the 2A1 antigen of dendritic-cell intracellular granules
(unpublished data) or the FAll antigen of macrophage intracellular granules (21). (a and d) Phase-contrast images of the cytocentrifuged cells
fixed in acetone. (b and e) MHC class II monoclonal antibody N22 (24) (ATCC HB225). (c and f) Double-labeled cells with rat monoclonal
antibodies to intracellular antigens (2A1 and FAll, respectively). (a-c) Loosely attached dendritic cell-enriched population. (d-J) Firmly
attached macrophage-enriched population. (b and c) The dendritic-cell fraction stains strongly for MHC class II and 2A1 intracellular antigens.
Two such dendritic cells are indicated by arrows. (e and f) The macrophage fraction expresses little or no MHC class II but high levels of the
FAll intracellular antigen (a single class II-rich profile is indicated by arrows). The staining sequence was N22 hamster anti-mouse class II,
biotin-conjugated rabbit anti-hamster immunoglobulin (Jackson ImmunoResearch), Texas red-streptavidin (Biomedia, Foster City, CA), 2A1
or FAll rat monoclonal antibody, and fluorescein-conjugated mouse anti-rat immunoglobulin (Boehringer Mannheim). (x250.)
uct plus other accessory functions [e.g., the ligation of
several adhesion or costimulatory molecules including CD2,
CD11a, and CD28 (1)].
The nonadherent cells from the colonies (containing gran-
ulocytes and dendritic cells) and the loosely adherent cells
(containing primarily dendritic cells; Fig. 3 a-c) were very
much enriched relative to the bulk or unfractionated popu-
lation in MLR stimulating activity (Fig. 4, compare data for
weakly adherent and nonadherent GM-colony populations
with that for the bulk GM-colony population). The strongly
adherent GM-colony macrophages were inactive. The










able from splenic dendritic cells in MLR stimulating activity
(Fig. 4, compare weakly adherent GM-colony population and
spleen dendritic cells). Some of the methylcellulose colonies
were not of the "mixed" type but contained either typical
macrophages and granulocytes as described (15). When cells
from these colonies were tested, no MLR stimulating activity
was apparent.
DISCUSSION
Bowers and Berkowitz (27) first reported that dendritic cells
could be generated from MHC class II-negative precursors in
.2 0 Spleen dendritic cell
V
Cells from GM colony
* Bulk population
v Nonadherent population
A Weak adherent population
* * Strong adherent population
Cells from M colony
O Bulk population
* Cells from G colony
* Bulk population
103 104
Stimulator cells, no. per well
FIG. 4. MLR stimulating activity of various cell types derived from GM-CSF-induced bone marrow colonies. GM-CSF was used to induce
the formation of colonies from MHC class II-negative precursors as in Fig. 1. Cells from mixed colonies (containing both macrophages and
granulocytes, GM colony) or from pure macrophage (M colony) and granulocyte (G colony) colonies were plucked from the methylcellulose
semi-solid cultures, washed, mitomycin C-treated, and used to stimulate an allogeneic MLR in 3 x 105 purified T cells from C3H H-2k mice.
The cells in the mixed GM colonies were separated into fractions as in Fig. 3. The nonadherent fraction contains both granulocytes and dendritic
cells, the weakly adherent fraction is primarily dendritic cells, and the strongly adherent fraction is primarily macrophages. The MLR was
monitored by measuring DNA synthesis in the T cells ([3H]thymidine uptake) at 72-90 h of culture.
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serum-free suspension cultures of rat bone marrow. By
adding GM-CSF, much larger numbers of granulocytes,
macrophages, and dendritic cells can be generated (13). Reid
et al. (16) observed that bulk populations of human bone
marrow or blood cells would generate mixed colonies of
macrophages and dendritic cells upon supplementation with
a lectin-stimulated leukocyte-conditioned medium that likely
contained GM-CSF. Recently, Reid et al. (17) have docu-
mented that GM-CSF and tumor necrosis factor work to-
gether to generate colonies containing macrophages and
dendritic cells or dendritic cells only.
Here we show that dendritic cells share a common MHC
class II-negative colony-forming precursor with phagocytes
(granulocytes and macrophages), by using the classical GM-
CSF semi-solid bioassay. We were unable to detect pure
dendritic-cell colonies. In mixed colonies, the dendntic cells
were enumerated and distinguished from typical phagocytes
by the following features: a dendritic or veiled morphology,
weak adherence to plastic, and distinct antigenic markers
including high levels of MHC class II products and new
intracellular antigens. Since this small subset of dendritic
cells could be enriched by adherence methods, it was pos-
sible to study the T-cell stimulating activity of different cell
types from mixed colonies and from pure macrophage and
granulocyte colonies. The MLR stimulating activity of col-
ony-derived dendritic cells was very strong and comparable
to that seen in mature lymphoid dendritic cells, whereas the
phagocytes lacked detectable activity (Fig. 4). Therefore, by
the criteria that we have studied, the dendritic cells differ
markedly from the macrophages and granulocytes that are
also arising from MHC class II-negative progenitors within
individual colonies.
The extent to which this distinct immunostimulatory, dif-
ferentiation pathway occurs in bone marrow in vivo is un-
clear. Typical dendritic cells have not been identified in fresh
bone marrow suspensions and are rare in blood, whereas
mature granulocytes and macrophages are found in both
sites. In vivo, dendritic cell development may not proceed to
the same extent in marrow as in these semi-solid colony-
forming systems. Prolonged exposure to GM-CSF, or other
cytokines yet to be identified, may be required to induce the
full development of MHC class II-rich immunostimulatory
dendritic cells.
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